Cargando…
A Case Study in Generic Drug Use: Should There Be Risk Adjustment in Incentive Payments for the Use of Generic Medications?
BACKGROUND: Encouraging generic drug use has reduced health care costs for payers and consumers, but the availability of therapeutically interchangeable medications or generic medications of choice is not equal across disease states. The extent to which systems of care are able to substitute with ge...
Autores principales: | Walton, Surrey M., Rash, Christine, Lambert, Bruce L., Galanter, William L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441025/ https://www.ncbi.nlm.nih.gov/pubmed/25351970 http://dx.doi.org/10.18553/jmcp.2014.20.11.1093 |
Ejemplares similares
-
Prescription Drug Costs and the Generic Dispensing Ratio
por: Liberman, Joshua N., et al.
Publicado: (2010) -
Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?
por: Son, Kyung-Bok
Publicado: (2023) -
The Use of Generic Medications for Glaucoma
por: Tatham, Andrew J.
Publicado: (2020) -
Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs
por: Hammami, Muhammad M., et al.
Publicado: (2017) -
Interchangeability of Generic Drugs: A Nonparametric Pharmacokinetic Model of Gabapentin Generic Drugs
por: Glerum, Pieter J., et al.
Publicado: (2018)